Global Cancer Stem Cells Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 2013

Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample.
Over the past few years, stem cells are being successfully utilized in immuno-reconstitution and for replenishment of blood after tumor development or after tumor treatment.
In 2018, the global Cancer Stem Cells market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cancer Stem Cells status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Stem Cells development in United States, Europe and China.

The key players covered in this study
Thermo Fisher Scientific
Abbvie
Merck Kgaa
Bionomics
Lonza
Stemline Therapeutics
Miltenyi Biotec
Promocell
Macrogenics
Oncomed Pharmaceuticals
Irvine Scientific
Stemcell Technologies
Sino Biological
Biotime

Market segment by Type, the product can be split into
Cell Culturing
Cell Separation
Cell Analysis
Molecular Analysis
Others

Market segment by Application, split into
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cancer Stem Cells status, future forecast, growth opportunity, key market and key players.
To present the Cancer Stem Cells development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cancer Stem Cells are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Stem Cells Market Size Growth Rate by Type (2014-2025)
1.4.2 Cell Culturing
1.4.3 Cell Separation
1.4.4 Cell Analysis
1.4.5 Molecular Analysis
1.4.6 Others
1.5 Market by Application
1.5.1 Global Cancer Stem Cells Market Share by Application (2014-2025)
1.5.2 Breast Cancer Diagnosis and Treatment
1.5.3 Prostate Cancer Diagnosis and Treatment
1.5.4 Colorectal Cancer Diagnosis and Treatment
1.5.5 Lung Cancer Diagnosis and Treatment
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Cancer Stem Cells Market Size
2.2 Cancer Stem Cells Growth Trends by Regions
2.2.1 Cancer Stem Cells Market Size by Regions (2014-2025)
2.2.2 Cancer Stem Cells Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Cancer Stem Cells Market Size by Manufacturers
3.1.1 Global Cancer Stem Cells Revenue by Manufacturers (2014-2019)
3.1.2 Global Cancer Stem Cells Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cancer Stem Cells Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Stem Cells Key Players Head office and Area Served
3.3 Key Players Cancer Stem Cells Product/Solution/Service
3.4 Date of Enter into Cancer Stem Cells Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Cancer Stem Cells Market Size by Type (2014-2019)
4.2 Global Cancer Stem Cells Market Size by Application (2014-2019)

5 United States
5.1 United States Cancer Stem Cells Market Size (2014-2019)
5.2 Cancer Stem Cells Key Players in United States
5.3 United States Cancer Stem Cells Market Size by Type
5.4 United States Cancer Stem Cells Market Size by Application

6 Europe
6.1 Europe Cancer Stem Cells Market Size (2014-2019)
6.2 Cancer Stem Cells Key Players in Europe
6.3 Europe Cancer Stem Cells Market Size by Type
6.4 Europe Cancer Stem Cells Market Size by Application

7 China
7.1 China Cancer Stem Cells Market Size (2014-2019)
7.2 Cancer Stem Cells Key Players in China
7.3 China Cancer Stem Cells Market Size by Type
7.4 China Cancer Stem Cells Market Size by Application

8 Japan
8.1 Japan Cancer Stem Cells Market Size (2014-2019)
8.2 Cancer Stem Cells Key Players in Japan
8.3 Japan Cancer Stem Cells Market Size by Type
8.4 Japan Cancer Stem Cells Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Cancer Stem Cells Market Size (2014-2019)
9.2 Cancer Stem Cells Key Players in Southeast Asia
9.3 Southeast Asia Cancer Stem Cells Market Size by Type
9.4 Southeast Asia Cancer Stem Cells Market Size by Application

10 India
10.1 India Cancer Stem Cells Market Size (2014-2019)
10.2 Cancer Stem Cells Key Players in India
10.3 India Cancer Stem Cells Market Size by Type
10.4 India Cancer Stem Cells Market Size by Application

11 Central & South America
11.1 Central & South America Cancer Stem Cells Market Size (2014-2019)
11.2 Cancer Stem Cells Key Players in Central & South America
11.3 Central & South America Cancer Stem Cells Market Size by Type
11.4 Central & South America Cancer Stem Cells Market Size by Application

12 International Players Profiles
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Stem Cells Introduction
12.1.4 Thermo Fisher Scientific Revenue in Cancer Stem Cells Business (2014-2019)
12.1.5 Thermo Fisher Scientific Recent Development
12.2 Abbvie
12.2.1 Abbvie Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Stem Cells Introduction
12.2.4 Abbvie Revenue in Cancer Stem Cells Business (2014-2019)
12.2.5 Abbvie Recent Development
12.3 Merck Kgaa
12.3.1 Merck Kgaa Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Stem Cells Introduction
12.3.4 Merck Kgaa Revenue in Cancer Stem Cells Business (2014-2019)
12.3.5 Merck Kgaa Recent Development
12.4 Bionomics
12.4.1 Bionomics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Stem Cells Introduction
12.4.4 Bionomics Revenue in Cancer Stem Cells Business (2014-2019)
12.4.5 Bionomics Recent Development
12.5 Lonza
12.5.1 Lonza Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Stem Cells Introduction
12.5.4 Lonza Revenue in Cancer Stem Cells Business (2014-2019)
12.5.5 Lonza Recent Development
12.6 Stemline Therapeutics
12.6.1 Stemline Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Stem Cells Introduction
12.6.4 Stemline Therapeutics Revenue in Cancer Stem Cells Business (2014-2019)
12.6.5 Stemline Therapeutics Recent Development
12.7 Miltenyi Biotec
12.7.1 Miltenyi Biotec Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Stem Cells Introduction
12.7.4 Miltenyi Biotec Revenue in Cancer Stem Cells Business (2014-2019)
12.7.5 Miltenyi Biotec Recent Development
12.8 Promocell
12.8.1 Promocell Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cancer Stem Cells Introduction
12.8.4 Promocell Revenue in Cancer Stem Cells Business (2014-2019)
12.8.5 Promocell Recent Development
12.9 Macrogenics
12.9.1 Macrogenics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cancer Stem Cells Introduction
12.9.4 Macrogenics Revenue in Cancer Stem Cells Business (2014-2019)
12.9.5 Macrogenics Recent Development
12.10 Oncomed Pharmaceuticals
12.10.1 Oncomed Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cancer Stem Cells Introduction
12.10.4 Oncomed Pharmaceuticals Revenue in Cancer Stem Cells Business (2014-2019)
12.10.5 Oncomed Pharmaceuticals Recent Development
12.11 Irvine Scientific
12.12 Stemcell Technologies
12.13 Sino Biological
12.14 Biotime

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details